Human papilloma virus vaccine for palmoplantar warts: A retrospective study of 18 patients
Corresponding Author
Léa Merio
Department of Dermatology, AP-HP, University Hospital of Henri Mondor, Créteil, France
Correspondence
Léa Merio, Department of Dermatology, University Hospital of Henri Mondor, 1 rue Gustave Eiffel, 94000, Creteil – 0149812501, France.
Email: [email protected]
Search for more papers by this authorJohan Chanal
Department of Dermatology, AP-HP, University Hospital of Paris Centre, Paris, France
Search for more papers by this authorMarie Jachiet
Department of Dermatology, AP-HP, University Hospital of Saint-Louis, Paris, France
Search for more papers by this authorValérie Pourcher
Department of Infectious Disease, AP-HP, Sorbonne University, University Hospital of Pitié-Salpêtrière, Paris, France
Search for more papers by this authorJean Philippe Arnault
Department of Dermatology, University Hospital of Amiens-Picardie, Amiens, France
Search for more papers by this authorChristelle Jouhet
Private Office of Dermatology, Avignon, France
Search for more papers by this authorBrigitte Milpied-Homsi
Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France
Search for more papers by this authorIsabelle Bourgault-Villada
Department of Dermatology and Clinical Immunology, AP-HP, University Hospital of Ambroise Paré, Boulogne, France
Search for more papers by this authorFrancois Aubin
Department of Dermatology and Inserm 1098, University Regional Hospital of Besançon, Besançon, France
Search for more papers by this authorFrédéric Caux
Department of Dermatology, AP-HP, University Hospital of Avicenne, Bobigny, France
Search for more papers by this authorSébastien Fouéré
Center for Genital Pathology and STIs and HPV platform, AP-HP, University Hospital of Saint-Louis, Paris, France
Search for more papers by this authorEric Vicaut
Clinical Research Unit of Lariboisière-Saint-Louis, AP-HP, Paris, France
Search for more papers by this authorMarie Beylot-Barry
Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France
Search for more papers by this authorOlivier Chosidow
Department of Dermatology, AP-HP, University Hospital of Henri Mondor, Créteil, France
Infestious Diseases and Sexually Transmitted Infection Working Group
Search for more papers by this authorwith the support of the GrIDIST
Infestious Diseases and Sexually Transmitted Infection Working Group
Search for more papers by this authorCorresponding Author
Léa Merio
Department of Dermatology, AP-HP, University Hospital of Henri Mondor, Créteil, France
Correspondence
Léa Merio, Department of Dermatology, University Hospital of Henri Mondor, 1 rue Gustave Eiffel, 94000, Creteil – 0149812501, France.
Email: [email protected]
Search for more papers by this authorJohan Chanal
Department of Dermatology, AP-HP, University Hospital of Paris Centre, Paris, France
Search for more papers by this authorMarie Jachiet
Department of Dermatology, AP-HP, University Hospital of Saint-Louis, Paris, France
Search for more papers by this authorValérie Pourcher
Department of Infectious Disease, AP-HP, Sorbonne University, University Hospital of Pitié-Salpêtrière, Paris, France
Search for more papers by this authorJean Philippe Arnault
Department of Dermatology, University Hospital of Amiens-Picardie, Amiens, France
Search for more papers by this authorChristelle Jouhet
Private Office of Dermatology, Avignon, France
Search for more papers by this authorBrigitte Milpied-Homsi
Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France
Search for more papers by this authorIsabelle Bourgault-Villada
Department of Dermatology and Clinical Immunology, AP-HP, University Hospital of Ambroise Paré, Boulogne, France
Search for more papers by this authorFrancois Aubin
Department of Dermatology and Inserm 1098, University Regional Hospital of Besançon, Besançon, France
Search for more papers by this authorFrédéric Caux
Department of Dermatology, AP-HP, University Hospital of Avicenne, Bobigny, France
Search for more papers by this authorSébastien Fouéré
Center for Genital Pathology and STIs and HPV platform, AP-HP, University Hospital of Saint-Louis, Paris, France
Search for more papers by this authorEric Vicaut
Clinical Research Unit of Lariboisière-Saint-Louis, AP-HP, Paris, France
Search for more papers by this authorMarie Beylot-Barry
Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France
Search for more papers by this authorOlivier Chosidow
Department of Dermatology, AP-HP, University Hospital of Henri Mondor, Créteil, France
Infestious Diseases and Sexually Transmitted Infection Working Group
Search for more papers by this authorwith the support of the GrIDIST
Infestious Diseases and Sexually Transmitted Infection Working Group
Search for more papers by this authorOpen Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012; 3:CD001781.
- 2Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010; 146: 475–7.
- 3Daniel BS, Murrell DF. Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine. JAMA Dermatol. 2013; 149: 370–2.
- 4Abeck D, Fölster-Holst R. Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children. Acta Derm Venereol. 2015; 95: 1017–9.
- 5Yang M-Y, Son J-H, Kim G-W, et al. Quadrivalent human papilloma virus vaccine for the treatment of multiple warts: a retrospective analysis of 30 patients. J Dermatolog Treat. 2019; 30: 405–9.
- 6Waldman A, Whiting D, Rani M, et al. HPV vaccine for treatment of recalcitrant cutaneous warts in adults: a retrospective cohort study. Dermatologic Surgery. 2019; 45: 1739–41.
- 7Ly K, Sh C, Jy P, et al. The Quadrivalent Human Papillomavirus Vaccine in Recalcitrant Non-genital Warts: A Retrospective Study. Ann Acad Med Singap. 2020; 49: 749–55.
- 8Kost Y, Deutsch A, Zhu TH, et al. Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year old. J. Am. Acad Dermatol. 2021; 87: 250–2.
Citing Literature
